Hypertension and metabolic syndrome: Impact of clustering of hypertension in subjects with metabolic syndrome

Pakistan Journal of Medical Sciences

Volumn 23, Issue 6, 2007, Pages 903-908

  Khan, Sikandar Hayat ^a,b   Khan, Farooq Ahmad ^a   Ijaz, Amir ^a   Sattar, Abdus ^a   Dilawar, Mohammad ^a   Hashim, Rizwan ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b Greater Karsaz Area   (Pakistan)

Author keywords

Adult treatment panel III; Homeostasis model assessment for insulin resistance; Hypertension; Metabolic syndrome; National cholesterol education program

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; EDUCATION PROGRAM; FEMALE; GLUCOSE TRANSPORT; GROUPS BY AGE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 36949014563     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Zarich SW. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events. Rev Cardiovasc Med 2005;6(4): 194-205.
2. Cheal LK, Abbasi F, Lamendola C, MC Laughlin T, Reaven MG, Ford SE. Relationship to insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome. Diabetes 2004; 53: 1195-1200.
3. Grundy MS. Etiology of the Metabolic Syndrome-Reply. JAMA 2004; 291 (12): 1444.
4. Pausova Z. From big fat cells to high blood pressure: A pathway to obesity-associated hypertension. Curr Opin Nephrol Hypertens 2006; 15(2):173-8.
5. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM; San Antonio Heart Study. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26(11):3153-9.
6. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26(3):575-81.
7. Fujiwara T, Saitoh S, Takagi S, Takeuchi H, Isobe T, Chiba Y, et al. Development and progression of atherosclerotic disease in relation to insulin resistance & hyperinsulinemia. Hypertens Res 2005; 28(8):665-70.
8. Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, et al. Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis Risk in Communities Study Investigators. J Hypertens 1999; 17(8):1169-77.
9. Ernsberger P, Koletsky RJ. Metabolic effects of antihypertensive agents: Role of sympathoadrenal and renin-angiotensin systems. Naunyn Schmiedebergs Arch Pharmacol 2006; 373(4):245-58.
10. Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Drugs 2004; 64(22):2537-65.
11. Cordero Fort A, Moreno Arribas J, Alegria Ezquerra E. Is essential hypertension essentially metabolic? Med Clin (Barc) 2006; 127(18):705-8.
12. Srinivasan SR, Myers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension 2006; 48(1):33-9.
13. Velarde G, Berk BC. Role of hypertension in the metabolic syndrome: who is affected? Curr Hypertens Rep 2005; 7(6):418-26.
14. Monsalve MV, Thommasen HV, Pachev G, Frohlich J. Differences in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia. Med Sci Moint 2005; 11(1): CR21-8.
15. Almeida-Pititto B, Gimeno SG, Freire RD, Ribeiro-Filho FF, Ferreira SR. Leptin is not associated independently with hypertension in Japanese-Brazilian women. Braz J Med Biol Res 2006; 39(1):99-105.
16. Cabezas-Cerrato J, Garcia-Estevez DA, Araujo-Vilar D. Lack of association between both insulin resistance and plasma insulin levels with blood pressure values in essential hypertension. Horm Metab Res1997;29:561-5.
17. Toft I, Bonaa KH, Jenssen T. Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension 1998; 32:115-22.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint National Committee Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor GA, Treacher DF, Turner RL. Homeostasis model assessment: insulin resistance and b-cell function from plasma glucose insulin concentrations in man. Diabetologia 1985;28: 412-9.
20. Cordero A, Laclaustra M, Leon M, Grima A, Casasnovas JA, Luengo E, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment: A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry Substudy. Am J Hypertens 2006; 19(2):189-96.
21. Zavaroni I, Ardigo D, Zuccarelli A, Pacetti E, Piatti PM, Monti L, et al. Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutr Metab Cardiovasc Dis 2006; 16(1):22-7.
22. Fujiwara K, Hayashi K, Matsuda H, Kubota E, Honda M, Ozawa Y, et al. Altered pressure-natriuresis in obese Zucker rats. Hypertension 1999;33(6):1470-5.
23. De Castro Ra, Moncau Je, Marcopito Lf. Hypertension prevalence in the city of Formiga, MG, Brazil. Arq Bras Cardiol 2007; 88(3):334-9.
24. Ghosh R. Microlevel determinants of blood pressure among women of two ethnic groups in a periurban area of Kolkata city, India. Am J Hum Biol 2007;19(3):409-15.
25. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: A meta-analysis.Circulation 1998;97:996-1001.
26. Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, et al. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J 2006;151(3):754.
27. Anan F, Yonemochi H, Masaki T, Takahashi N, Fukunaga N, Teshima Y, et al. High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res 2007;30(2):125-31.
28. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003;26:669-76.
29. Kusuma YS, Babu BV, Naidu JM. Group and sex-specific effects of age, body composition and pulse rate on blood pressure variability in some cross-cultural populations of Visakhapatnam District; South India. J Cardiovasc Risk 2001;8:337-47.
30. Afsar B, Sezer S, Elsurer R, Ozdemir FN. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?Blood Press Monit2007;12:133-9.
31. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R; Chennai Urban Population Study (CUPS No. 4). Intra-urban differences in the prevalence of the metabolic syndrome in southern India - the Chennai Urban Population Study (CUPS No.4). Diabet Med 2001;18:280-7.
32. Birkenhager AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med 2007; 65:127-131.